Muscle Growth & Performance Peptides: The Complete Hub

Category: Hub Type: Pillar Page Read Time: 28 minutes Author: Peptides.NYC Editorial Last Updated: 2026-05-19 URL: https://peptides.nyc/learn/hubs/muscle

Overview

The phrase "best muscle building peptides" gets typed into search bars by lifters who have hit a wall, athletes chasing a plateau-buster, and biohackers curious whether a syringe of CJC-1295 will outperform another year of progressive overload. The honest answer sits between the hype videos and the dismissive forum posts.

Peptides for muscle growth are not steroids. They do not bind the androgen receptor, do not shut down the HPTA the way exogenous testosterone does, and — with the partial exception of IGF-1 LR3 — do not produce the dramatic, often unsustainable mass gains associated with classic anabolic-androgenic steroids (AAS). What muscle peptides do is amplify or unlock specific pathways the body already uses to build tissue: pulsatile growth hormone (GH) release, IGF-1 signaling, satellite cell activation, and myostatin inhibition.

Used intelligently, that's a powerful toolkit. Used as a steroid replacement, most users end up disappointed.

This pillar page is the central map for everything Peptides.NYC publishes on muscle and performance peptides. We cover:

• GH secretagogues — CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, Hexarelin, MK-677
• The IGF-1 family — IGF-1 LR3, MGF, PEG-MGF
• Myostatin antagonists — Follistatin 344, ACE-031 (and why the latter was discontinued)
• Recovery peptides that support training volume — BPC-157, TB-500
• Body recomposition compounds — AOD-9604, 5-Amino-1MQ

Each section links to a full child protocol so you can drill down. The goal of this page is orientation: figuring out which family fits your goal, your risk tolerance, and your willingness to do bloodwork.

Why bodybuilders and athletes use muscle peptides

There are four realistic reasons to add peptides to a training program:

1. You want a cleaner anabolic signal without androgenic side effects — peptides won't crash testosterone or cause aromatization.
2. You're recovering from training volume that exceeds what your body can repair naturally — BPC-157 and TB-500 shine here.
3. You're optimizing GH/IGF-1 levels that have declined with age — secretagogues are far safer than exogenous HGH.
4. You've truly maxed natural recovery and want a measured experiment — IGF-1 LR3 or MGF in carefully cycled protocols.

What peptides will not do: turn a 175-pound natural lifter into a 220-pound contest-ready bodybuilder in one cycle. That's a steroid promise, not a peptide reality.

The mechanism gap that matters

Here's the single most important concept on this entire page: steroids and muscle peptides act on different parts of the anabolic system.

Anabolic-androgenic steroids work primarily through the androgen receptor (AR), which is expressed densely in muscle tissue. AR activation directly drives myofibrillar protein synthesis, increases nitrogen retention, and modulates a cascade of secondary anabolic pathways. The signaling is fast, powerful, and largely unbounded by the body's normal homeostatic brakes.

Muscle peptides act through three mostly separate channels:

1. The somatotropic axis (GH → IGF-1) — Secretagogues like CJC-1295 and Ipamorelin trigger pulsatile GH release. GH itself does little to muscle directly; its downstream effector is hepatic and local IGF-1. This system is still subject to negative feedback (somatostatin), so it's self-limiting.
2. Satellite cell biology — IGF-1 LR3 and MGF activate satellite cells, the quiescent precursor pool that supplies new myonuclei to growing fibers. This is a slower, regenerative mechanism rather than a brute-force protein synthesis driver.
3. Myostatin / activin signaling — Follistatin and (formerly) ACE-031 release a developmental brake on muscle growth. Effects in adults are smaller than in animal models or congenital cases.

Notice what's missing: none of these channels saturate the androgen receptor. That's the gap between peptide and steroid outcomes, and no peptide stack will close it.

Disclaimer: This content is for educational purposes only and is not medical advice. Muscle peptides discussed here are research compounds. Many are not FDA-approved for human use, several are explicitly banned by WADA, and some (notably IGF-1 LR3 and Follistatin) carry serious theoretical risks including tumor promotion. Consult a licensed healthcare provider before starting any protocol.

The Muscle Peptide Families

Most muscle peptides fall into one of four functional buckets. Memorize this table — it's the skeleton everything else hangs on.

The vast majority of natural lifters who try peptides get 80% of the available benefit from the bottom three rows alone (secretagogues + recovery + recomp). The top two rows — IGF-1 and myostatin inhibitors — are advanced territory with meaningfully higher risk.

GH Secretagogues — The Foundation

If muscle peptides have a "default starting point," it's the GH secretagogue category. These compounds don't introduce exogenous GH the way HGH injections do. Instead, they coax your own pituitary into releasing more of its own GH in a more youthful pulsatile pattern.

Why this matters for muscle: GH itself is only mildly anabolic to muscle tissue directly. Its main contribution is upstream — it drives hepatic IGF-1 production, improves nitrogen retention, supports collagen synthesis (tendons, joints), and improves recovery between training sessions. Combine that with deeper slow-wave sleep (a documented GH-secretagogue effect) and you get a compound that rebuilds the body's recovery capacity rather than forcing growth.

The most common stack is a GHRH analog + GHRP combination. The two work synergistically: the GHRH analog increases the size of the GH pulse, while the GHRP increases pulse frequency and amplitude. CJC-1295 (no DAC) + Ipamorelin is the canonical pairing.

• See: GH Secretagogue Protocol — full breakdown of every option in this class
• See: GH Peptide Stacking Guide — how to combine them effectively

For most natural athletes, a properly run GH secretagogue stack delivers visible body composition changes over 12–16 weeks with minimal downside. The effects are modest but real, and they compound with training and nutrition rather than substituting for them.

Quick differentiation within the class:

• CJC-1295 (no DAC) — Short-acting GHRH analog; pairs with GHRP for pulsed signaling. Most common choice.
• CJC-1295 (with DAC) — Long-acting via albumin binding; produces a "GH bleed" rather than pulses. Less physiological.
• Sermorelin — Original GHRH analog (1–29 fragment); very short half-life, modest effect, excellent safety record.
• Tesamorelin — FDA-approved GHRH analog (for HIV-associated lipodystrophy); strongest visceral fat reduction in the class.
• Ipamorelin — Clean ghrelin mimetic; minimal cortisol or prolactin effect. The standard GHRP pairing choice.
• GHRP-2 / GHRP-6 — Older ghrelin mimetics; stronger GH pulse but more appetite stimulation (especially GHRP-6).
• Hexarelin — Strongest acute GH releaser but desensitizes rapidly; rarely the right long-term choice.
• MK-677 (Ibutamoren) — Oral, very long-acting; convenient but causes water retention and appetite increase.

IGF-1 LR3 — The Anabolic Workhorse

If GH secretagogues are the foundation, IGF-1 LR3 is the building it can support — at a cost.

IGF-1 LR3 is an engineered analog of insulin-like growth factor 1. It has been modified at two positions: a substitution at amino acid 3 (Arg replaces Glu), and the addition of a 13-amino-acid extension at the N-terminus. The result is a molecule with dramatically reduced binding to IGFBPs (IGF-binding proteins) and a half-life of roughly 20–30 hours, compared to ~10 minutes for native IGF-1.

In plain English: it stays in circulation, stays bioactive, and binds the IGF-1 receptor freely. This is why bodybuilders use it. It's also why it's the most controversial muscle peptide on this page.

What IGF-1 LR3 does:

• Directly activates the IGF-1 receptor on muscle cells
• Stimulates satellite cell proliferation and differentiation
• Promotes nitrogen retention and protein synthesis
• Can drive measurable lean mass gains in 4–6 week cycles

Why it's risky:

• IGF-1 is a known mitogen. Elevated IGF-1 levels are associated in epidemiological data with increased risk of certain cancers (prostate, colorectal, breast). The dose-response and causation aren't fully settled, but the signal is real enough that endocrinologists take it seriously.
• Hypoglycemia is a real acute risk, especially at higher doses or when combined with insulin or fasted training.
• IGF-1 LR3 does not respond to the body's normal IGFBP buffering — it floods receptors in a way native IGF-1 doesn't.

This is not a beginner compound. It's not a "let me try peptides" compound. It's a tool for advanced users who understand the cancer-mitogen tradeoff, get bloodwork, and cycle conservatively.

• See: IGF-1 LR3 Protocol — dosing, site injection theory, cancer caveats in detail

MGF / PEG-MGF — Localized Growth

MGF (Mechano Growth Factor) is a splice variant of IGF-1 that the body produces locally in response to muscle damage. Where systemic IGF-1 is the chronic anabolic signal, MGF is the acute repair signal — it's released by stretched, loaded, or damaged muscle fibers and recruits satellite cells to the site of injury.

PEG-MGF is the synthetic, pegylated version. Pegylation extends the half-life from minutes to days, making subcutaneous administration practical.

The theoretical use case is elegant: inject PEG-MGF near a lagging muscle group post-workout, recruit satellite cells specifically to that area, and grow it preferentially. Bodybuilders have used this strategy to bring up stubborn body parts — biceps peaks, calves, rear delts — with anecdotal success.

The hyperplasia debate: MGF is one of the few compounds with any plausible claim to inducing true muscle fiber hyperplasia (new fibers, not just enlargement of existing ones). The evidence in humans is thin. In animal models, satellite cell activation can produce new myonuclei and possibly new fibers under specific conditions. In humans, the data is largely anecdotal and confounded by simultaneous training, nutrition, and stacking with other compounds.

What's reasonably established: MGF/PEG-MGF supports recovery and growth at the injection site, especially in combination with heavy resistance training and adequate nutrition.

• See: MGF / PEG-MGF Protocol — site injection technique, timing, cycle structure

Follistatin 344 — Releasing the Brake

Myostatin is a member of the TGF-beta family and acts as a negative regulator of muscle growth. The body produces it specifically to limit how much muscle you build — an evolutionary brake on tissue that's metabolically expensive to maintain.

Block myostatin and you release the brake. The most famous demonstration is the Belgian Blue cattle, which carry a natural myostatin loss-of-function mutation and look like four-legged bodybuilders. A small number of humans have been documented with similar mutations and show dramatically increased muscle mass from infancy.

Follistatin 344 is a peptide that binds and neutralizes myostatin (and activin), potentially allowing muscle growth beyond the body's normal regulatory ceiling.

The reality check:

• Human data on Follistatin 344 is extremely limited. Most evidence comes from animal models or gene therapy trials.
• The Belgian Blue/myostatin-null human comparison is misleading — those individuals had lifetime absence of myostatin signaling during development, not adult-onset short-term inhibition.
• Cardiac safety is a real concern. Myostatin is expressed in cardiac tissue and may play a role in cardiomyocyte regulation. Long-term myostatin inhibition could theoretically cause cardiac hypertrophy or dysfunction.
• Doses circulating in the bodybuilding community are essentially guesses extrapolated from animal studies.

Follistatin is an experimental compound. Cycles are typically short (2–3 weeks) and the long-term safety profile is unknown. Anyone considering it should have baseline cardiac imaging (echocardiogram) and be willing to repeat it.

• See: Follistatin 344 Protocol — what's known, what's guessed, how to think about cycling

ACE-031 — The Discontinued Drug (A Cautionary Tale)

ACE-031 deserves its own section because its story matters.

ACE-031 (also called ramatercept) is a soluble form of the activin type IIB receptor — essentially a decoy receptor that binds and neutralizes myostatin and related ligands. It was developed by Acceleron Pharma as a treatment for muscle-wasting diseases including Duchenne muscular dystrophy.

In early trials, ACE-031 looked promising: increased lean mass, decreased fat mass, modest functional improvements. It became a darling of underground bodybuilding forums.

Then, in 2013, Acceleron terminated the Phase 2 trial.

The reason: vascular adverse events. Trial subjects developed nosebleeds, gum bleeding, and telangiectasias (small dilated blood vessels visible at the skin surface). The mechanism isn't fully understood, but it likely relates to the broad activin/BMP family signaling that ACE-031 interfered with — these pathways are involved in vascular endothelial maintenance, not just muscle regulation.

The drug was never approved. Manufacturing for legitimate research effectively ceased. What you find on gray-market sites today is, at best, unregulated reproduction of a compound that failed safety trials in a controlled setting.

The lesson: "Discontinued in development" is not a marketing problem to be exploited. It's a clinical warning. When a pharmaceutical company with hundreds of millions invested in a drug walks away because of safety signals, that's the most credible safety review you'll ever get. ACE-031 is on this hub for completeness, but the protocol page exists primarily as a warning, not an instruction manual.

• See: ACE-031 / Myostatin Inhibitor Protocol — full clinical history and why caution is warranted

Sample Muscle-Building Stacks

Three example stacks across the risk spectrum. These are illustrative, not prescriptive — your protocol should be designed with a knowledgeable practitioner.

A note on the advanced stack: Even experienced users should treat this tier as a serious medical experiment. Baseline bloodwork (including IGF-1, fasting glucose, A1c, lipids, CBC, CMP), cardiac imaging if Follistatin is included, and ideally physician oversight are non-negotiable. The marginal gain over the intermediate stack is often smaller than the marginal risk.

For most natural-leaning athletes, the beginner stack run consistently for 12–16 weeks alongside disciplined training and nutrition will deliver more durable results than a single advanced cycle followed by months of fearful bloodwork.

How the stacks actually combine

The logic behind these stacks isn't random. Each compound is doing different work:

• CJC-1295 (GHRH) widens and sustains the GH pulse.
• Ipamorelin (GHRP) triggers and amplifies the pulse without raising cortisol.
• BPC-157 keeps tendons, ligaments, and gut tissue healthy enough to absorb training stress.
• IGF-1 LR3 delivers a direct anabolic signal that the GH-driven endogenous IGF-1 can't match in magnitude.
• PEG-MGF drives localized satellite cell recruitment to specific muscle groups.
• Follistatin removes the myostatin ceiling — briefly.

When you stack, you're layering complementary mechanisms. The mistake to avoid is redundant stacking — running two ghrelin mimetics simultaneously, or two GHRH analogs, doesn't compound the effect; it just spends more money on the same pathway.

Peptides vs Steroids — The Honest Comparison

The most common search query in this space is some variant of "peptides vs steroids." Here's the comparison you don't usually get on supplement-shilling websites.

The takeaway: peptides have a cleaner side effect profile, but they're also pulling on fewer anabolic levers. Steroids work by saturating the body's primary anabolic receptor system (androgen receptor) with supraphysiological signaling. Peptides amplify endogenous systems that already have biological brakes.

For someone whose priority is health-conscious optimization with measurable but moderate gains, peptides win. For someone whose priority is maximum mass gain at any cost, steroids will outperform — that's not an endorsement, it's a description of pharmacology.

Why Peptides Won't Replace Steroids for Mass

A blunt section, because the marketing in this space deserves a counterweight.

If you ask the question, "can I gain 30 pounds of lean mass in a year on peptides?" the answer for the overwhelming majority of users is no. Even with IGF-1 LR3, MGF, and full GH-axis support, the realistic ceiling for adult lean mass gain in a 12-month period is in the range of 8–15 pounds for an intermediate trainee — and that assumes everything else (training, nutrition, sleep) is dialed.

Why? Three reasons.

1. No androgen receptor saturation. Testosterone and its analogs are uniquely anabolic because the androgen receptor lives in muscle tissue and drives protein synthesis pathways that the GH/IGF axis touches only indirectly.

2. Endogenous regulation. GH secretagogues still respond to somatostatin feedback. Your body still produces myostatin (Follistatin only blocks a fraction of it). Your body still buffers IGF-1 with binding proteins (except in the case of IGF-1 LR3, which is part of why LR3 is the most "steroid-like" peptide).

3. No nitrogen retention overdrive. Steroids dramatically increase nitrogen retention; peptides nudge it.

This isn't a reason to dismiss peptides. It's a reason to set expectations honestly. Peptides are complementary to natural training, not a substitute pathway to steroid-like outcomes. The athletes getting the most from them are using them to extend recovery, sharpen body composition, and break specific plateaus — not to replace a decade of consistent training with a syringe.

For Specific Goals

Different goals call for different stacks. A non-exhaustive map:

• See: Fat Loss & Body Recomposition Peptide Protocol — full coverage of the recomp side

Bloodwork & Monitoring

If you take only one practical thing from this hub, take this: muscle peptides require bloodwork. Especially anything in the IGF-1 family, anything that affects glucose, and anything you plan to run for more than 8 weeks.

A reasonable monitoring panel:

The reason this matters isn't paranoia — it's that the side effects most likely to hurt you on muscle peptides are silent and slow: insulin resistance creeping up, IGF-1 trending well above the reference range, lipids drifting. You won't feel them until you have a metabolic problem. Bloodwork is how you catch the drift while it's still cheap to fix.

See: Bloodwork Checklist for a printable lab requisition guide.

Side Effects & Safety

Across the muscle-peptide category, the most common adverse effects are:

• Water retention — Common on GHRPs and especially MK-677; usually resolves once dose stabilizes or after discontinuation.
• Increased appetite — Strong with GHRP-6 and MK-677 (both ghrelin mimetics); useful in bulking, problematic in cutting.
• Tingling / numbness — Often a sign of carpal tunnel-like symptoms from GH/IGF axis activation. Usually transient; persistent symptoms warrant dose reduction.
• Hypoglycemia — Acute risk with IGF-1 LR3, especially when injected fasted or pre-workout. Have fast-acting carbs nearby.
• Injection site reactions — Redness, lumps, occasional tenderness; usually rotation and proper technique resolve it.
• Headache and lethargy — Some users experience this on GHRH analogs; often dose-dependent.

The longer-term and more serious concerns:

• Cancer mitogen concerns (IGF-1 family). Chronically elevated IGF-1 is associated in epidemiological data with increased risk of several cancers. The relationship is not fully causal, and within-normal-range fluctuations are unlikely to be dangerous, but supraphysiological IGF-1 sustained for months is a real concern. Cycle aggressively and verify your IGF-1 doesn't run far above normal range.
• Cardiac hypertrophy and dysfunction (myostatin inhibitors). Long-term safety unknown. Cardiac imaging recommended.
• Insulin resistance (GH axis). GH is counter-regulatory to insulin. Long-running secretagogue use without monitoring can drift glucose tolerance.
• Vascular events (ACE-031 specifically). Discontinued for this reason.

See: Peptide Safety Guide for the full framework.

WADA Status — Critical for Tested Athletes

If you compete in any tested sport — Olympic-pathway, IPF, NCAA, professional sports, even some amateur federations — read this carefully.

The bottom line for tested athletes: essentially every compound on this hub is banned. WADA's testing technology has improved dramatically, including biological passport approaches that detect anomalous IGF-1 patterns even without catching the parent compound. The "they can't test for peptides" claim is roughly 15 years out of date.

If you're tested, this hub is informational only. Do not use these compounds in a tested context.

Cycling Strategy

Cycling isn't optional for most of these compounds. It's the only way to balance benefit, side effect mitigation, and long-term safety.

General cycling principles:

1. Pyramid into a stack, don't add everything at once. Establish tolerance and side effect profile compound by compound.
2. Pull bloodwork during the cycle, not just at the end. A 6-week midpoint check on an IGF cycle can save you a bigger problem later.
3. Off periods are not just "rest" — they're recovery. Endocrine systems need time to recalibrate.
4. Don't chain cycles indefinitely. Two to three cycles per year is more than enough for most goals; perpetual on-cycle is where chronic risks emerge.

Top 10 Muscle Peptide FAQ

Q: Are peptides legal? A: It depends on the compound and the jurisdiction. Most muscle peptides in the US are sold as "research chemicals" and are not approved for human use. Some are FDA-approved for specific medical indications (Sermorelin, Tesamorelin) but used off-label in this space. None of this should be construed as legal advice.

Q: Will peptides shut down my natural testosterone? A: GH secretagogues and IGF family compounds don't suppress the HPTA the way anabolic steroids do. IGF-1 LR3 can mildly suppress native IGF-1 feedback but doesn't crash testosterone. Peptide PCT, if needed, is much lighter than steroid PCT. See: Peptide PCT Protocol.

Q: Can I gain muscle on peptides alone, without training? A: No. Peptides amplify your body's response to training stimulus. Without the stimulus, the signal has nothing to act on. This is true even for IGF-1 LR3 — without resistance training, you'll get some general anabolism but nothing close to the marketed claims.

Q: How long until I see results? A: GH secretagogues typically show subjective effects (sleep, recovery, skin) in 2–4 weeks and measurable body composition changes by 8–12 weeks. IGF-1 LR3 can show visible changes in 2–4 weeks. Recovery peptides like BPC-157 typically show benefit within 1–3 weeks.

Q: Do peptides cause cancer? A: There's no evidence that GH secretagogues cause cancer. The concern is specifically with IGF-1 — chronically supraphysiological IGF-1 levels are associated with increased risk of certain cancers in epidemiological data. The "association" is not the same as "causation," but it's a real signal worth respecting.

Q: What's the safest muscle peptide? A: BPC-157 has the cleanest safety profile and is the lowest-risk starting point if your goal is supporting training recovery. For an actual mass-building effect, CJC-1295 + Ipamorelin is the safest combination with meaningful results.

Q: Can I stack muscle peptides with testosterone or steroids? A: This is common in the bodybuilding community but multiplies the risks — particularly cardiac, lipid, and glucose. If you're on TRT or AAS, the addition of GH-axis or IGF-axis compounds requires more aggressive bloodwork and ideally physician oversight.

Q: How do I know I'm getting real peptides? A: Third-party COA (Certificate of Analysis) showing >98% purity, HPLC + mass spec testing, proper lyophilization (white powder), and a vendor with reputational track record. See: Vendor Scorecard Framework and COA Reading Guide.

Q: Do I need a doctor to do this? A: Legally, peptides used for performance are off-label or research-only. Practically, having a healthcare provider involved — particularly one who runs and interprets bloodwork — dramatically improves your safety. Several compounding pharmacies in NYC work with knowledgeable physicians. See: Compounding Pharmacy Guide.

Q: What happens when I stop? A: Effects taper over weeks. GH secretagogue benefits (sleep, recovery) fade first; body composition gains hold longer if training and nutrition remain consistent. IGF-1 LR3 gains are more dependent on continued anabolic signaling; some loss is expected post-cycle. This isn't a "permanent damage" scenario — it's an "anabolic signal returns to baseline" scenario.

Featured Protocols on Peptides.NYC

The deep-dive child protocols for everything covered in this hub:

• IGF-1 LR3 Protocol — the anabolic workhorse, in detail
• Follistatin 344 Protocol — myostatin inhibition with appropriate caution
• ACE-031 / Myostatin Inhibitor Protocol — clinical history and cautionary review
• MGF / PEG-MGF Protocol — localized growth and satellite cell theory
• GH Secretagogue Protocol — full breakdown of CJC, Ipa, Sermorelin, Tesamorelin, MK-677
• GH Peptide Stacking Guide — combining GHRH + GHRP effectively
• Fat Loss & Body Recomposition Protocol — the recomp side of muscle peptides

Supporting content:

• BPC-157 Complete Guide — recovery foundation
• TB-500 Complete Guide — soft tissue repair
• Bloodwork Checklist — what to test, when, why
• Peptide PCT Protocol — recovery between cycles
• Beginners Stack Guide — entry-level protocols
• Injection Safety Checklist — practical safety
• Vendor Scorecard Framework — sourcing intelligently

Disclaimer: This content is for educational purposes only and is not medical advice. Muscle and performance peptides discussed on this page are research compounds; many are not FDA-approved for human use, several carry serious theoretical risks (particularly the IGF-1 family with respect to cancer mitogen concerns, and Follistatin/ACE-031 with respect to cardiac and vascular safety), and essentially all are prohibited by WADA for tested athletes. Consult a licensed healthcare provider before starting any protocol. Peptides.NYC does not sell peptides and does not provide medical advice.

Source: https://peptides.nyc/learn/hubs/muscle